LORBRENA 25 MG 30 F.C.TAB

INDICATED FOR THE TREATMENT OF PATIENTS WITH ALK-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC). IT WORKS BY INHIBITING THE ACTIVITY OF THE ABNORMAL ANAPLASTIC LYMPHOMA KINASE (ALK) PROTEIN, THEREBY SLOWING OR STOPPING THE GROWTH OF CANCER CELLS.